Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hangzhou Biotest Biotech CoSHSE:688767 +4.35%72 OCF Margin % is 20.83% as of Jun. 2026, which is 12% below its 10-year median of 23.76. GuruFocus rates SHSE:688767 with a GF Score™ of 72/100 and a GF Value™ of ¥28.40 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Hangzhou Biotest Biotech Co ranks better than 78.21% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688767 vs VRTX, REGN, MRNA: OCF Margin % Comparison
For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Biotest Biotech Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Hangzhou Biotest Biotech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Biotest Biotech Co (SHSE:688767) has a OCF Margin % of 20.83% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hangzhou Biotest Biotech Co and its competitors. This is 12% below median its historical median of 23.76. Over the past decade, Hangzhou Biotest Biotech Co's OCF Margin % has ranged from 5.81 to 51.55. According to the industry distribution chart, Hangzhou Biotest Biotech Co ranks #209 out of 959 companies in the Biotechnology industry, placing it in the top 21.8%.
Is Hangzhou Biotest Biotech Co's OCF Margin % too high?
Hangzhou Biotest Biotech Co's current OCF Margin % of 20.83% is 12% below median its 10-year median of 23.76. Over the past 10 years, this metric has ranged from a low of 5.81 to a high of 51.55. Based on the distribution chart, Hangzhou Biotest Biotech Co ranks #209 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou Biotest Biotech Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Biotest Biotech Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Biotest Biotech Co ranks #209 out of 959 companies for OCF Margin %. This places Hangzhou Biotest Biotech Co in the top 22% of its industry — outperforming the majority of peers. Historically, Hangzhou Biotest Biotech Co's own OCF Margin % has ranged from 5.81 to 51.55 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hangzhou Biotest Biotech Co and its competitors. Hangzhou Biotest Biotech Co's current OCF Margin % is 20.83%, which is 12% below median its own 10-year median of 23.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Biotest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co (SHSE:688767) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥28.40, compared to a current price of ¥38.61 — trading 36% above its estimated fair value. The current OCF Margin % is 20.83%, which is 12% below median its 10-year median of 23.76. Hangzhou Biotest Biotech Co's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hangzhou Biotest Biotech Co (SHSE:688767), the current OCF Margin % is 20.83% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Biotest Biotech Co (SHSE:688767) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co stock appears to be overvalued.
The current stock price of ¥38.61 is trading 36% above its estimated GF Value™ of ¥28.40.
GuruFocus considers Hangzhou Biotest Biotech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688767:
OCF Margin %: 20.83% (12% below median its 10-year median of 23.76)
GF Value™: ¥28.40 vs. price of ¥38.61 (36% above fair value)
No single metric tells the full story. See the SHSE:688767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
72GF Score
Get the complete analysis for SHSE:688767
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688767 has been successfully added to your 
